focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,983.00
Bid: 1,990.00
Ask: 1,991.00
Change: -45.00 (-2.22%)
Spread: 1.00 (0.05%)
Open: 2,030.00
High: 2,034.00
Low: 1,980.00
Prev. Close: 2,028.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks advance despite economic worries

Fri, 01st Oct 2010 12:23

London's leading share index remains in positive territory, but worries over the European debt situation have weighed on sentiment slightly.The concerns centre on Ireland again, after figures showed manufacturing activity in the country contracted in September, with the purchasing managers' index falling to 48.4 from 51.1 in August. A reading above 50 indicates expansion.Manufacturing figures here were much better, but nothing to shout about. The Markit/Chartered Institute of Purchasing and Supply manufacturing PMI index fell to 53.4 in September from 53.7 the previous month, suggesting growth figures for the third quarter will be subdued.Despite the gloom, there was some positive company news for traders to ponder. BP is higher amid speculation that dividends will soon be resumed. Bob Dudley, who becomes chief executive of the oil company today, said that the board would meet soon to discuss restoring payouts next year, according to newspaper reports. But it is BP's rival BG that is causing most excitement. BG's Spanish peer Repsol has announced a deal with the Chinese refiner Sinopec, which will result in Sinopec holding a 40% stake in Repsol's Brazilian unit. BG Group and Repsol have been exploring for oil in waters of Brazil in partnership and the deal is also seen as supportive to BG.In the FTSE 250, drugs group Hikma Pharmaceuticals has moved to calm fears about the impact of a plan by US regulators to ban unapproved oral colchicine products to treat gout. The company said it will comply with any FDA regulatory requirements related to the sale of colchicine "if such a notice is served", but still predicts 20% revenue growth for its US generics business for the full year 2010 "irrespective of the timing of such notification".Having thought about it all week Cooper Controls has launched a rival bid for Mount Engineering at 82p a share, topping Redhall's 70p a share offer. Spectris, the mid-cap instrumentation and controls company, has bought American maker of rugged industrial networking components N-TRON for $51m (£32m).FTSE 100 - RisersBG Group (BG.) 1,166.00p +4.25%ARM Holdings (ARM) 404.50p +3.14%BP (BP.) 440.60p +2.99%Land Securities Group (LAND) 656.50p +2.50%Weir Group (WEIR) 1,458.00p +2.46%Capital Shopping Centres Group (CSCG) 375.90p +2.23%Vedanta Resources (VED) 2,206.00p +1.89%Tullow Oil (TLW) 1,298.00p +1.88%African Barrick Gold (ABG) 600.00p +1.69%Lonmin (LMI) 1,697.00p +1.68%FTSE 100 - FallersExperian Group (EXPN) 682.50p -1.52%Cobham (COB) 227.90p -1.34%Compass Group (CPG) 524.00p -1.23%Aggreko (AGK) 1,551.00p -1.21%Rolls-Royce Group (RR.) 597.00p -1.08%Resolution (RSL) 243.00p -0.82%Morrison (Wm) Supermarkets (MRW) 293.30p -0.81%Aviva (AV.) 395.80p -0.78%Burberry Group (BRBY) 1,032.00p -0.77%Severn Trent (SVT) 1,301.00p -0.76%FTSE 250 - RisersPace (PIC) 181.20p +4.14%Victrex (VCT) 1,328.00p +4.08%TalkTalk Telecom Group (TALK) 152.50p +3.95%Helical Bar (HLCL) 308.10p +3.53%Hargreaves Lansdown (HL.) 454.90p +3.39%Mondi (MNDI) 530.00p +3.01%Great Portland Estates (GPOR) 351.40p +2.96%Shaftesbury (SHB) 445.20p +2.84%Electrocomponents (ECM) 249.70p +2.84%Derwent London (DLN) 1,546.00p +2.79%FTSE 250 - FallersYell Group (YELL) 14.40p -2.51%CPP Group (CPP) 260.00p -2.44%Moneysupermarket.com (MONY) 80.45p -1.83%Hochschild Mining (HOC) 437.00p -1.80%CSR (CSR) 352.70p -1.75%Howden Joinery Group (HWDN) 75.25p -1.51%United Business Media (UBM) 620.00p -1.51%Hansen Transmissions International (HSN) 46.90p -1.47%Supergroup (SGP) 1,198.00p -1.40%Stobart Group Ltd. (STOB) 152.20p -1.36%
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.